OncoMed Pharmaceuticals Announces First Quarter 2014 Financial Results
[GlobeNewswire] – REDWOOD CITY, Calif. — OncoMed Pharmaceuticals, Inc. , a clinical-stage company developing novel therapeutics that target cancer stem cells (CSCs), or tumor-initiating cells, today reported financial … more
View todays social media effects on OMED
View the latest stocks trending across Twitter. Click to view dashboard